Please log in to save bookmarks. Only registered users can save their favorite pages.
Journal Properties
Number of Articles
170
e-ISSN
2153-0645
Publisher
OMICS Publishing Group
Indian UGC
DOAJ (latest)
Description
The Journal of Pharmacogenomics & Pharmacoproteomics is a peer-reviewed, open-access journal that publishes cutting-edge research at the intersection of genomics, proteomics, and pharmacology. It is dedicated to understanding how genetic and protein variations influence drug response, efficacy, and toxicity. The journal plays a vital role in advancing personalized medicine by providing a platform for scientists and clinicians to share their findings on how individual genetic and protein profiles can be used to optimize drug therapy.
It covers a broad range of topics, including the identification of pharmacogenomic and pharmacoproteomic biomarkers, the development of diagnostic tools, and the application of these findings in clinical practice. Further are areas such as drug metabolism, drug transport, and drug target interactions. The journal showcases research on novel therapeutic strategies that are tailored to individual patient characteristics.
Indexed in major databases such as PubMed, Scopus, and Web of Science, the Journal of Pharmacogenomics & Pharmacoproteomics offers a valuable resource for researchers, clinicians, and pharmaceutical professionals seeking to stay at the forefront of this rapidly evolving field. We encourage you to contribute to our shared knowledge by submitting your latest research.